ID   BACH2_HUMAN             Reviewed;         841 AA.
AC   Q9BYV9; E1P518; Q59H70; Q5T793; Q9NTS5;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-JAN-2026, entry version 193.
DE   RecName: Full=Transcription regulator protein BACH2;
DE   AltName: Full=BTB and CNC homolog 2;
GN   Name=BACH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10949928; DOI=10.1038/sj.onc.1203716;
RA   Sasaki S., Ito E., Toki T., Maekawa T., Kanezaki R., Umenai T., Muto A.,
RA   Nagai H., Kinoshita T., Yamamoto M., Inazawa J., Taketo M.M., Nakahata T.,
RA   Igarashi K., Yokoyama M.;
RT   "Cloning and expression of human B cell-specific transcription factor BACH2
RT   mapped to chromosome 6q15.";
RL   Oncogene 19:3739-3749(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11746976; DOI=10.1002/gcc.1200;
RA   Vieira S.A.D., Deininger M.W.N., Sorour A., Sinclair P., Foroni L.,
RA   Goldman J.M., Melo J.V.;
RT   "Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL
RT   oncogene.";
RL   Genes Chromosomes Cancer 32:353-363(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-521, AND MUTAGENESIS
RP   OF SER-521.
RX   PubMed=17018862; DOI=10.1182/blood-2005-12-040972;
RA   Yoshida C., Yoshida F., Sears D.E., Hart S.M., Ikebe D., Muto A., Basu S.,
RA   Igarashi K., Melo J.V.;
RT   "Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear
RT   translocation of the transcription factor Bach2, which represses the
RT   antiapoptotic factor heme oxygenase-1.";
RL   Blood 109:1211-1219(2007).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-382 AND LYS-421, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN IMD60, VARIANTS IMD60 PRO-24
RP   AND LYS-788, AND CHARACTERIZATION OF VARIANTS IMD60 PRO-24 AND LYS-788.
RX   PubMed=28530713; DOI=10.1038/ni.3753;
RA   Afzali B., Groenholm J., Vandrovcova J., O'Brien C., Sun H.W.,
RA   Vanderleyden I., Davis F.P., Khoder A., Zhang Y., Hegazy A.N.,
RA   Villarino A.V., Palmer I.W., Kaufman J., Watts N.R., Kazemian M.,
RA   Kamenyeva O., Keith J., Sayed A., Kasperaviciute D., Mueller M.,
RA   Hughes J.D., Fuss I.J., Sadiyah M.F., Montgomery-Recht K., McElwee J.,
RA   Restifo N.P., Strober W., Linterman M.A., Wingfield P.T., Uhlig H.H.,
RA   Roychoudhuri R., Aitman T.J., Kelleher P., Lenardo M.J., O'Shea J.J.,
RA   Cooper N., Laurence A.D.J.;
RT   "BACH2 immunodeficiency illustrates an association between super-enhancers
RT   and haploinsufficiency.";
RL   Nat. Immunol. 18:813-823(2017).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 9-129, SUBUNIT, AND INTERCHAIN
RP   DISULFIDE BOND.
RX   PubMed=22194330; DOI=10.1107/s0907444911048335;
RA   Rosbrook G.O., Stead M.A., Carr S.B., Wright S.C.;
RT   "The structure of the Bach2 POZ-domain dimer reveals an intersubunit
RT   disulfide bond.";
RL   Acta Crystallogr. D 68:26-34(2012).
CC   -!- FUNCTION: Transcriptional regulator that acts as a repressor or
CC       activator (By similarity). Binds to Maf recognition elements (MARE) (By
CC       similarity). Plays an important role in coordinating transcription
CC       activation and repression by MAFK (By similarity). Induces apoptosis in
CC       response to oxidative stress through repression of the antiapoptotic
CC       factor HMOX1 (PubMed:17018862). Positively regulates the nuclear import
CC       of actin (By similarity). Is a key regulator of adaptive immunity,
CC       crucial for the maintenance of regulatory T-cell function and B-cell
CC       maturation (PubMed:28530713). {ECO:0000250|UniProtKB:P97303,
CC       ECO:0000269|PubMed:17018862, ECO:0000269|PubMed:28530713}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:22194330). Heterodimer of
CC       BACH2 and Maf-related transcription factors (By similarity).
CC       {ECO:0000250|UniProtKB:P97303, ECO:0000269|PubMed:22194330}.
CC   -!- INTERACTION:
CC       Q9BYV9; Q3KP44: ANKRD55; NbExp=3; IntAct=EBI-1642333, EBI-14493093;
CC       Q9BYV9; Q9BXS5: AP1M1; NbExp=3; IntAct=EBI-1642333, EBI-541426;
CC       Q9BYV9; Q8TBE0: BAHD1; NbExp=3; IntAct=EBI-1642333, EBI-742750;
CC       Q9BYV9; Q9NR55: BATF3; NbExp=6; IntAct=EBI-1642333, EBI-10312707;
CC       Q9BYV9; Q9HC52: CBX8; NbExp=3; IntAct=EBI-1642333, EBI-712912;
CC       Q9BYV9; Q8N715: CCDC185; NbExp=3; IntAct=EBI-1642333, EBI-740814;
CC       Q9BYV9; Q6IPU0: CENPP; NbExp=3; IntAct=EBI-1642333, EBI-10250303;
CC       Q9BYV9; Q5T655: CFAP58; NbExp=3; IntAct=EBI-1642333, EBI-10245749;
CC       Q9BYV9; Q9UBR2: CTSZ; NbExp=3; IntAct=EBI-1642333, EBI-8636823;
CC       Q9BYV9; Q2TBE0: CWF19L2; NbExp=3; IntAct=EBI-1642333, EBI-5453285;
CC       Q9BYV9; Q14241: ELOA; NbExp=3; IntAct=EBI-1642333, EBI-742350;
CC       Q9BYV9; Q6UWV6: ENPP7; NbExp=3; IntAct=EBI-1642333, EBI-12047821;
CC       Q9BYV9; Q3B820: FAM161A; NbExp=3; IntAct=EBI-1642333, EBI-719941;
CC       Q9BYV9; O95363: FARS2; NbExp=3; IntAct=EBI-1642333, EBI-2513774;
CC       Q9BYV9; P15408: FOSL2; NbExp=5; IntAct=EBI-1642333, EBI-3893419;
CC       Q9BYV9; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-1642333, EBI-740641;
CC       Q9BYV9; Q6ZSG2: INSYN2A; NbExp=3; IntAct=EBI-1642333, EBI-12146621;
CC       Q9BYV9; Q92993: KAT5; NbExp=3; IntAct=EBI-1642333, EBI-399080;
CC       Q9BYV9; Q9P127: LUZP4; NbExp=3; IntAct=EBI-1642333, EBI-10198848;
CC       Q9BYV9; Q9ULX9: MAFF; NbExp=5; IntAct=EBI-1642333, EBI-721128;
CC       Q9BYV9; O15525: MAFG; NbExp=6; IntAct=EBI-1642333, EBI-713514;
CC       Q9BYV9; O60675: MAFK; NbExp=5; IntAct=EBI-1642333, EBI-2559512;
CC       Q9BYV9; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-1642333, EBI-348259;
CC       Q9BYV9; Q9UH92-3: MLX; NbExp=3; IntAct=EBI-1642333, EBI-8852072;
CC       Q9BYV9; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-1642333, EBI-398874;
CC       Q9BYV9; P62195: PSMC5; NbExp=3; IntAct=EBI-1642333, EBI-357745;
CC       Q9BYV9; P32969: RPL9P9; NbExp=3; IntAct=EBI-1642333, EBI-358122;
CC       Q9BYV9; Q9BUL9: RPP25; NbExp=3; IntAct=EBI-1642333, EBI-366570;
CC       Q9BYV9; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-1642333, EBI-748391;
CC       Q9BYV9; O75387: SLC43A1; NbExp=3; IntAct=EBI-1642333, EBI-9661945;
CC       Q9BYV9; Q8NB12: SMYD1; NbExp=3; IntAct=EBI-1642333, EBI-8463848;
CC       Q9BYV9; Q15560: TCEA2; NbExp=3; IntAct=EBI-1642333, EBI-710310;
CC       Q9BYV9; Q9BUZ4: TRAF4; NbExp=3; IntAct=EBI-1642333, EBI-3650647;
CC       Q9BYV9; Q8IWZ5: TRIM42; NbExp=3; IntAct=EBI-1642333, EBI-5235829;
CC       Q9BYV9; Q9NRE2: TSHZ2; NbExp=3; IntAct=EBI-1642333, EBI-10687282;
CC       Q9BYV9; O75386: TULP3; NbExp=5; IntAct=EBI-1642333, EBI-5357290;
CC       Q9BYV9; O43167: ZBTB24; NbExp=4; IntAct=EBI-1642333, EBI-744471;
CC       Q9BYV9; Q8NCN2: ZBTB34; NbExp=4; IntAct=EBI-1642333, EBI-11317716;
CC       Q9BYV9; Q15973: ZNF124; NbExp=3; IntAct=EBI-1642333, EBI-2555767;
CC       Q9BYV9; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-1642333, EBI-11962468;
CC       Q9BYV9; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-1642333, EBI-10251462;
CC       Q9BYV9; Q3KQV3: ZNF792; NbExp=3; IntAct=EBI-1642333, EBI-10240849;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17018862,
CC       ECO:0000269|PubMed:28530713}. Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00978, ECO:0000269|PubMed:17018862,
CC       ECO:0000269|PubMed:28530713}. Note=Nucleocytoplasmic shuttling is
CC       controlled by phosphorylation. {ECO:0000269|PubMed:17018862}.
CC   -!- TISSUE SPECIFICITY: B-cell specific.
CC   -!- PTM: Phosphorylation at Ser-521 downstream of the PI-3K pathway
CC       promotes nuclear export. {ECO:0000269|PubMed:17018862}.
CC   -!- PTM: The reversible disulfide bond may provide a mechanism to regulate
CC       the activity in oxidative stress responses.
CC       {ECO:0000269|PubMed:22194330}.
CC   -!- DISEASE: Immunodeficiency 60 and autoimmunity (IMD60) [MIM:618394]: An
CC       autosomal dominant primary immunologic disorder characterized by
CC       intestinal inflammation, recurrent sino-pulmonary infections, impaired
CC       lymphocyte maturation, and variably decreased immunoglobulin
CC       production. {ECO:0000269|PubMed:28530713}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the bZIP family. CNC subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92126.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/741/BACH2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF357835; AAK48898.1; -; mRNA.
DR   EMBL; AJ271878; CAC28130.1; -; mRNA.
DR   EMBL; AB208889; BAD92126.1; ALT_INIT; mRNA.
DR   EMBL; AL353692; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48530.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48531.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48532.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48533.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48534.1; -; Genomic_DNA.
DR   CCDS; CCDS5026.1; -.
DR   RefSeq; NP_001164265.1; NM_001170794.2.
DR   RefSeq; NP_068585.1; NM_021813.4.
DR   PDB; 3OHU; X-ray; 2.10 A; A/B/C/D/E/F=9-129.
DR   PDB; 3OHV; X-ray; 2.20 A; A/B/C/D/E/F=9-129.
DR   PDBsum; 3OHU; -.
DR   PDBsum; 3OHV; -.
DR   AlphaFoldDB; Q9BYV9; -.
DR   SMR; Q9BYV9; -.
DR   BioGRID; 121913; 86.
DR   ComplexPortal; CPX-2471; bZIP transcription factor complex, BACH2-NFE2L3.
DR   ComplexPortal; CPX-2473; bZIP transcription factor complex, BACH2-NFE2L1.
DR   ComplexPortal; CPX-2479; bZIP transcription factor complex, BACH2-MAFB.
DR   ComplexPortal; CPX-2482; bZIP transcription factor complex, BACH2-MAFK.
DR   ComplexPortal; CPX-2483; bZIP transcription factor complex, BACH2-MAF.
DR   ComplexPortal; CPX-2484; bZIP transcription factor complex, BACH2-MAFF.
DR   ComplexPortal; CPX-2485; bZIP transcription factor complex, BACH2-MAFG.
DR   ComplexPortal; CPX-2487; bZIP transcription factor complex, BACH2-BACH2.
DR   ComplexPortal; CPX-7093; bZIP transcription factor complex, BACH2-BATF3.
DR   FunCoup; Q9BYV9; 2124.
DR   IntAct; Q9BYV9; 80.
DR   STRING; 9606.ENSP00000257749; -.
DR   ChEMBL; CHEMBL5069364; -.
DR   GlyCosmos; Q9BYV9; 9 sites, 2 glycans.
DR   GlyGen; Q9BYV9; 11 sites, 2 O-linked glycans (9 sites).
DR   iPTMnet; Q9BYV9; -.
DR   PhosphoSitePlus; Q9BYV9; -.
DR   BioMuta; BACH2; -.
DR   DMDM; 17433037; -.
DR   jPOST; Q9BYV9; -.
DR   MassIVE; Q9BYV9; -.
DR   PaxDb; 9606-ENSP00000257749; -.
DR   PeptideAtlas; Q9BYV9; -.
DR   ProteomicsDB; 79726; -.
DR   Antibodypedia; 31919; 234 antibodies from 30 providers.
DR   DNASU; 60468; -.
DR   Ensembl; ENST00000257749.9; ENSP00000257749.4; ENSG00000112182.17.
DR   Ensembl; ENST00000343122.7; ENSP00000345642.3; ENSG00000112182.17.
DR   Ensembl; ENST00000406998.7; ENSP00000384145.3; ENSG00000112182.17.
DR   Ensembl; ENST00000453877.6; ENSP00000397668.2; ENSG00000112182.17.
DR   Ensembl; ENST00000695952.1; ENSP00000512284.1; ENSG00000112182.17.
DR   GeneID; 60468; -.
DR   KEGG; hsa:60468; -.
DR   MANE-Select; ENST00000257749.9; ENSP00000257749.4; NM_021813.4; NP_068585.1.
DR   UCSC; uc003pnw.4; human.
DR   AGR; HGNC:14078; -.
DR   CIViC; 60468; 2 evidence items across 2 molecular profiles.
DR   ClinPGx; PA25235; -.
DR   CTD; 60468; -.
DR   DisGeNET; 60468; -.
DR   GeneCards; BACH2; -.
DR   HGNC; HGNC:14078; BACH2.
DR   HPA; ENSG00000112182; Group enriched (bone marrow, lymphoid tissue).
DR   MalaCards; BACH2; -.
DR   MIM; 605394; gene.
DR   MIM; 618394; phenotype.
DR   OpenTargets; ENSG00000112182; -.
DR   VEuPathDB; HostDB:ENSG00000112182; -.
DR   eggNOG; KOG3863; Eukaryota.
DR   GeneTree; ENSGT00940000158228; -.
DR   HOGENOM; CLU_015243_0_0_1; -.
DR   InParanoid; Q9BYV9; -.
DR   OMA; MMGDGMY; -.
DR   OrthoDB; 6365358at2759; -.
DR   PAN-GO; Q9BYV9; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9BYV9; -.
DR   PathwayCommons; Q9BYV9; -.
DR   SignaLink; Q9BYV9; -.
DR   SIGNOR; Q9BYV9; -.
DR   Agora; ENSG00000112182; -.
DR   BioGRID-ORCS; 60468; 14 hits in 1208 CRISPR screens.
DR   ChiTaRS; BACH2; human.
DR   EvolutionaryTrace; Q9BYV9; -.
DR   GeneWiki; BACH2; -.
DR   GenomeRNAi; 60468; -.
DR   Pharos; Q9BYV9; Tbio.
DR   PRO; PR:Q9BYV9; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9BYV9; protein.
DR   Bgee; ENSG00000112182; Expressed in cortical plate and 174 other cell types or tissues.
DR   ExpressionAtlas; Q9BYV9; baseline and differential.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:ComplexPortal.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IPI:ComplexPortal.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0051170; P:import into nucleus; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; NAS:ComplexPortal.
DR   GO; GO:0090721; P:primary adaptive immune response involving T cells and B cells; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd18278; BTB_POZ_BACH2; 1.
DR   CDD; cd14719; bZIP_BACH; 1.
DR   FunFam; 1.10.880.10:FF:000002; transcription regulator protein BACH2 isoform X1; 1.
DR   FunFam; 3.30.710.10:FF:000033; transcription regulator protein BACH2 isoform X1; 1.
DR   Gene3D; 3.30.710.10; Potassium Channel Kv1.1, Chain A; 1.
DR   Gene3D; 1.10.880.10; Transcription factor, Skn-1-like, DNA-binding domain; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR043321; bZIP_BACH.
DR   InterPro; IPR004826; bZIP_Maf.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR008917; TF_DNA-bd_sf.
DR   InterPro; IPR050457; ZnFinger_BTB_dom_contain.
DR   PANTHER; PTHR46105; AGAP004733-PA; 1.
DR   PANTHER; PTHR46105:SF8; TRANSCRIPTION REGULATOR PROTEIN BACH2; 1.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF03131; bZIP_Maf; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF47454; A DNA-binding domain in eukaryotic transcription factors; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Cytoplasm; Disease variant; Disulfide bond;
KW   DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..841
FT                   /note="Transcription regulator protein BACH2"
FT                   /id="PRO_0000076456"
FT   DOMAIN          37..103
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   DOMAIN          646..709
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          153..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          204..226
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          246..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          583..610
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          651..667
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          671..678
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          777..816
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           821..841
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        160..172
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        214..224
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        298..313
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        584..598
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97303"
FT   MOD_RES         521
FT                   /note="Phosphoserine; by RPS6KB1"
FT                   /evidence="ECO:0000269|PubMed:17018862"
FT   DISULFID        20
FT                   /note="Interchain; redox-active"
FT                   /evidence="ECO:0000269|PubMed:22194330"
FT   CROSSLNK        382
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         24
FT                   /note="L -> P (in IMD60; impairs protein stability; the
FT                   mutant is unsoluble and forms multiple aggregates)"
FT                   /evidence="ECO:0000269|PubMed:28530713"
FT                   /id="VAR_082216"
FT   VARIANT         418
FT                   /note="A -> T (in dbSNP:rs34335140)"
FT                   /id="VAR_033535"
FT   VARIANT         788
FT                   /note="E -> K (in IMD60; uncertain significance; severely
FT                   decreased localization in the nucleus; the mutant
FT                   aggregates in the cytoplasm; dbSNP:rs757652995)"
FT                   /evidence="ECO:0000269|PubMed:28530713"
FT                   /id="VAR_082217"
FT   MUTAGEN         521
FT                   /note="S->A: Leads to nuclear accumulation."
FT                   /evidence="ECO:0000269|PubMed:17018862"
FT   CONFLICT        75
FT                   /note="V -> A (in Ref. 3; BAD92126)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        291
FT                   /note="L -> F (in Ref. 1; AAK48898)"
FT                   /evidence="ECO:0000305"
FT   STRAND          12..15
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   HELIX           19..33
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   HELIX           52..58
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   HELIX           60..66
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   HELIX           84..94
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   STRAND          97..101
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   TURN            103..105
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   HELIX           106..116
FT                   /evidence="ECO:0007829|PDB:3OHU"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:3OHU"
SQ   SEQUENCE   841 AA;  92537 MW;  4E926AC325952A93 CRC64;
     MSVDEKPDSP MYVYESTVHC TNILLGLNDQ RKKDILCDVT LIVERKEFRA HRAVLAACSE
     YFWQALVGQT KNDLVVSLPE EVTARGFGPL LQFAYTAKLL LSRENIREVI RCAEFLRMHN
     LEDSCFSFLQ TQLLNSEDGL FVCRKDAACQ RPHEDCENSA GEEEDEEEET MDSETAKMAC
     PRDQMLPEPI SFEAAAIPVA EKEEALLPEP DVPTDTKESS EKDALTQYPR YKKYQLACTK
     NVYNASSHST SGFASTFRED NSSNSLKPGL ARGQIKSEPP SEENEEESIT LCLSGDEPDA
     KDRAGDVEMD RKQPSPAPTP TAPAGAACLE RSRSVASPSC LRSLFSITKS VELSGLPSTS
     QQHFARSPAC PFDKGITQGD LKTDYTPFTG NYGQPHVGQK EVSNFTMGSP LRGPGLEALC
     KQEGELDRRS VIFSSSACDQ VSTSVHSYSG VSSLDKDLSE PVPKGLWVGA GQSLPSSQAY
     SHGGLMADHL PGRMRPNTSC PVPIKVCPRS PPLETRTRTS SSCSSYSYAE DGSGGSPCSL
     PLCEFSSSPC SQGARFLATE HQEPGLMGDG MYNQVRPQIK CEQSYGTNSS DESGSFSEAD
     SESCPVQDRG QEVKLPFPVD QITDLPRNDF QMMIKMHKLT SEQLEFIHDV RRRSKNRIAA
     QRCRKRKLDC IQNLECEIRK LVCEKEKLLS ERNQLKACMG ELLDNFSCLS QEVCRDIQSP
     EQIQALHRYC PVLRPMDLPT ASSINPAPLG AEQNIAASQC AVGENVPCCL EPGAAPPGPP
     WAPSNTSENC TSGRRLEGTD PGTFSERGPP LEPRSQTVTV DFCQEMTDKC TTDEQPRKDY
     T
//
